MI-773 (SAR405838)
95%
- Product Code: 101391
CAS:
1303607-60-4
| Molecular Weight: | 562.5 g./mol | Molecular Formula: | C₂₉H₃₄Cl₂FN₃O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
MI-773 (SAR405838) is primarily investigated for its potential in cancer therapy. It functions as an MDM2 inhibitor, targeting the interaction between MDM2 and the tumor suppressor protein p53. By disrupting this interaction, MI-773 activates p53, leading to the induction of apoptosis in cancer cells. This mechanism is particularly relevant in cancers with wild-type p53, where MDM2 overexpression often leads to p53 inactivation. Preclinical studies have shown promising results in various cancer models, including solid tumors and hematologic malignancies. Its application is being explored in combination therapies to enhance efficacy and overcome resistance to conventional treatments. Ongoing research aims to optimize its therapeutic potential and evaluate its safety profile in clinical trials.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 94.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿27,660.00 |
+
-
|
MI-773 (SAR405838)
MI-773 (SAR405838) is primarily investigated for its potential in cancer therapy. It functions as an MDM2 inhibitor, targeting the interaction between MDM2 and the tumor suppressor protein p53. By disrupting this interaction, MI-773 activates p53, leading to the induction of apoptosis in cancer cells. This mechanism is particularly relevant in cancers with wild-type p53, where MDM2 overexpression often leads to p53 inactivation. Preclinical studies have shown promising results in various cancer models, including solid tumors and hematologic malignancies. Its application is being explored in combination therapies to enhance efficacy and overcome resistance to conventional treatments. Ongoing research aims to optimize its therapeutic potential and evaluate its safety profile in clinical trials.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :